Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling

Key Points

• Psychedelics elicit distinct effects via 5-HT2A receptor pathway mediated Gi signalling, enhancing serotonin function.
• Activation of the 5-HT2A receptor initiates Gi signalling, leading to altered neurotransmission dynamics.
• The findings indicate potential therapeutic pathways, linking psychedelics and neurological conditions through specific receptor interactions.
• Further exploration of 5-HT2A receptor dynamics could yield insights into both psychedelic therapy and brain function.